Qlife reports Q2 2026 financial results and partnership progress
The company generated SEK 728k in revenue, advanced Egoo Health biomarker projects, and secured ISP approval for its rights issue while outlining future growth strategies.
Latest Qlife Holding News & Updates
See the latest news and media coverage for Qlife. We track all announcements, press releases, and industry mentions in real time, all in one place.
Last updated
Latest news about Qlife Holding (Qlife)
In short: Qlife secured ISO and U.S. patent approvals, completed a pharma feasibility study, and reported Q2 revenue.
Company announcements
Qlife publishes Q1 2026 interim report
Revenue was kSEK 21, EBITDA loss kSEK -5,502, and net loss kSEK -6,225.
Qlife announces rights issue outcome
The rights issue is subscribed to 82.9%, raising SEK 26 million. A directed issue of 202,500 shares is resolved to guarantors.
Qlife announces rights issue subscription ends 19 March 2026
Subscription period runs from 5 to 19 March 2026. Raises up to SEK 31.4 million at SEK 2 per share. Secured to 82.9% with commitments.
Media coverage
Qlife Secures ISO Certification for At-home Phenylalanine Testing
Qlife Holding AB is a Sweden-based medical technology Company that manufactures the hardware and software platform Egoo.health (Egoo) with which patients can carry out various...
Qlife Holding AB (publ) publishes its results for the second quarter and the first half-year ended June 30, 2026
Qlife Holding AB has published its financial results for the second quarter and the first half-year ended June 30, 2026. For the second quarter...
QLife Holding AB: Qlife resolves on a partially guaranteed rights issue of approx. SEK 31.4 million and proposes an over-allotment option, enters bridge loan agreements and ...
Aktien»Nachrichten»QLIFE AKTIE»QLife Holding AB: Qlife resolves on a partially guaranteed rights issue of approx. SEK 31.4 million and proposes an over-allotment option, enters bridge loan...
QLife Holding AB: Qlife enters letter of intent with Hipro Biotechnology Co., Ltd. to join forces through a reverse takeover
Qlife Holding AB ("Qlife" or the "Company") has entered into a non-binding letter of intent ("Letter of Intent") with Hipro Biotechnology Co., Ltd., registration no...
Never miss news about Qlife
Track Qlife and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.
SharkNinja
NRx
Ropes & Gray
HighTech Kaunas
inretrn
Poundland
Farrer & Co
Specialfastigheter
SISAB
Hemsö
Stenvalvet
Liljewall
Veidekke
Locum
NCC
Kriminalvården
Archus
Nyréns
Peab
MVB
VGR fastigheter
AIX
ByggDialog
Tengbom
LINK
Dynacon
Delphidata
Waystream
Netnod
Open Infra
PENN Entertainment
BrandCrowd
Itancia
Paul, Weiss
Prime Medicine
AN2 Therapeutics